CINCINNATI--(BUSINESS WIRE)--March 1, 2005--Chemed Corporation
("Chemed") (NYSE:CHE) today announced that its VITAS Healthcare
Corporation of Pennsylvania (VITAS) subsidiary has acquired Hospice of
Greater Pittsburgh Comfort Care located in Pittsburgh, Pennsylvania,
effective March 1, 2005. This acquisition adds approximately 85
patients to those cared for through VITAS' network of hospice
programs. VITAS is the nation's largest provider of end-of-life
hospice care services.
Terms of the transaction were not disclosed.
Timothy O'Toole, Chief Executive Officer of VITAS, stated, "VITAS
continues to build on its momentum in the acquisition arena with the
addition of this quality provider in the important Western
Pennsylvania market. A long-time leader in a competitive hospice
market, Hospice of Greater Pittsburgh has benefited from the active
involvement of its owners and earned a well-deserved reputation for
the quality of its end-of-life care and its record as a progressive
employer. VITAS is eager to build upon Hospice of Greater Pittsburgh's
success to further expand our reach in Western Pennsylvania."
The Hospice of Greater Pittsburgh acquisition follows VITAS' 2004
acquisitions of Haven House Hospice in Atlanta, Georgia, on August 26
and Premier Hospice and Palliative Care in Phoenix, Arizona, on
December 17. VITAS now operates 34 hospice programs in 12 states.
Listed on the New York Stock Exchange and headquartered in
Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two
wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is
the nation's largest provider of end-of-life hospice care and
Roto-Rooter is the nation's leading provider of plumbing and drain
Statements in this press release or in other Chemed communications
may relate to future events or Chemed's future performance. Such
statements are forward-looking statements and are based on present
information Chemed has related to its existing business circumstances.
Investors are cautioned that such forward-looking statements are
subject to inherent risk that actual results may differ materially
from such forward-looking statements. Further, investors are cautioned
that Chemed does not assume any obligation to update forward-looking
statements based on unanticipated events or changed expectations.
CONTACT: Chemed Corporation
David P. Williams, 513-762-6901
SOURCE: Chemed Corporation